This competitive renewal proposes to continue its strong track record of training future leaders of academic dermatology. Of the 21 trainees supported for one or more years by this T32 program during the past ten years and who have completed their subspecialty and/or research training, 12 subsequently received full- time appointments to academic department, with major basic and/or clinical research commitments for 10 of them. Our emphasis on the development of the research skills of MD and MD/PhD dermatologists will be maintained;although PhD candidates judged likely to make substantive contributions to investigative dermatology will be considered for unfilled positions. Our department provides an environment conducive to training research dermatologists: thirteen of the 28 full-time primary Dermatology faculties are actively engaged in basic and/or clinical research, spending more than 50% effort on such research activities;eight are identified as potential preceptors in this renewal application. Our dermatology-based research faculty interacts extensively with investigators from other departments at Yale, including 16 internationally recognized researchers designated as potential preceptors for this training program. Because we consider it most conducive to the trainees'development of intellectual independence and to the introduction of new scientific skills into the dermatology community, substantial exposure to outstanding basic scientists outside of our department will continue to be mandatory. As during the past two funding periods, each trainee will have two advisors, one inside and one outside the Dermatology Department. In the usual circumstance in which the principal laboratory experience is outside the department, under the mentorship of one of the designated non-dermatologist basic scientists or another equivalent individual, the Dermatology faculty advisor will monitor progress of the trainee and certify that the training program is relevant to the trainee's future in the specialty. Training opportunities will continue to be available throughout a broad range of research arenas relevant to cutaneous biology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32AR007016-38
Application #
8105192
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Cibotti, Ricardo
Project Start
1975-07-01
Project End
2015-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
38
Fiscal Year
2011
Total Cost
$234,300
Indirect Cost
Name
Yale University
Department
Dermatology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Perry, Curtis J; Muñoz-Rojas, Andrés R; Meeth, Katrina M et al. (2018) Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med 215:877-893
Neubert, Natalie J; Schmittnaegel, Martina; Bordry, Natacha et al. (2018) T cell-induced CSF1 promotes melanoma resistance to PD1 blockade. Sci Transl Med 10:
Dragovic, Srdjan M; Agunbiade, Tolulope A; Freudzon, Marianna et al. (2018) Immunization with AgTRIO, a Protein in Anopheles Saliva, Contributes to Protection against Plasmodium Infection in Mice. Cell Host Microbe 23:523-535.e5
Greiling, Teri M; Dehner, Carina; Chen, Xinguo et al. (2018) Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med 10:
Damsky, William; Thakral, Durga; Emeagwali, Nkiruka et al. (2018) Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis. N Engl J Med 379:2540-2546
Lilly, Evelyn; Bunick, Christopher G; Maley, Alexander M et al. (2018) More than keratitis, ichthyosis, and deafness: multisystem effects of lethal GJB2 mutations. J Am Acad Dermatol :
Wang, Jake; Perry, Curtis J; Meeth, Katrina et al. (2017) UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model. Pigment Cell Melanoma Res 30:428-435
Damsky, W E; Bosenberg, M (2017) Melanocytic nevi and melanoma: unraveling a complex relationship. Oncogene 36:5771-5792
Damsky, William; King, Brett A (2017) JAK inhibitors in dermatology: The promise of a new drug class. J Am Acad Dermatol 76:736-744
Bunick, Christopher G; Milstone, Leonard M (2017) The X-Ray Crystal Structure of the Keratin 1-Keratin 10 Helix 2B Heterodimer Reveals Molecular Surface Properties and Biochemical Insights into Human Skin Disease. J Invest Dermatol 137:142-150

Showing the most recent 10 out of 90 publications